Entries by https://www.sandoz.com/rss/feeds/news/media-releases.xml

Sandoz in-licenses brand and authorized generic of respiratory medicine Proventil® HFA (albuterol sulfate) Inhalation Aerosol from Kindeva Drug Delivery, with immediate generic availability in US

Albuterol sulfate is used to treat or prevent bronchospasm in patients four years and older with reversible obstructive airway disease, such as asthma, and to prevent exercise-induced bronchospasm1 Immediate launch of our authorized generic will help e…

Sandoz announces agreement to acquire GSK’s cephalosporin antibiotics business, reinforcing its leading global position in antibiotics

Sandoz to acquire three established brands sold in more than 100 marketsAcquisition, including leading global brand Zinnat®, confirms Sandoz commitment to antibiotics, following plans to expand its integrated manufacturing site in KundlTransaction comp…

Novartis delivered sales growth and margin expansion. Continued to progress its next wave of medicines in 2020.

Full year net sales from continuing operations¹ up 3% (cc², +3% USD):Pharmaceuticals BU grew 5% (cc) driven by Entresto (+44% cc), Zolgensma (reaching USD 0.9 billion), Cosentyx (+13% cc), Ilaris (+31% cc) and the Xiidra acquisition (+95% cc)Oncology B…

Sandoz officially certified as Global Top Employer 2021

Top Employers Institute recognizes Sandoz for its exceptional employee offerings globallyThird such annual certification for Sandoz underlines ongoing commitment to attract and keep best talent by building a great place to workBasel, January 25, 2021 –…

Novartis delivers solid Q3 performance with 11% core operating income growth, net sales in line with prior year, strong pipeline progression. Upgrades full year core operating income guidance.

Q3 net sales from continuing operations1were in line with prior year (cc2, +1% USD):Growth drivers included Entresto USD 632 million (+45% cc), Zolgensma USD 291 million (+79% cc), Cosentyx USD 1 012 million (+7% cc), Kisqali USD 183 million (+50% cc) …

Sandoz appoints new Board representative to global AMR Industry Alliance

Dominic De Souza, global head of Anti-Infectives sustainability and AMR program, appointed to represent Sandoz on AMR Industry AllianceAlliance brings together approximately 100 life science companies / associations in search of sustainable solutions t…

Sandoz Donates 20 critically needed generic medicines to hospitals and dispensaries in continued support of the people of Beirut

In continued support of the people of Beirut, Lebanon impacted by the August 4 port explosion and the ongoing rebuilding efforts, Sandoz has donated 20 critically needed generic medicines through the non-governmental organization (NGO), Beit el Baraka….

Sandoz launches its first RFID-tagged critical injectable medicines with Kit Check to optimize supply chain and automate restocking in US hospitals

First three Sandoz medicines labeled with RFID technology will be available in US hospitals starting in October, followed by several more through Q1 2021Sandoz and Kit Check together provide comprehensive solutions to hospital customers to lower costs,…

Sandoz announces plans for joint investment to help strengthen future of antibiotics manufacturing in Europe

Sandoz and Austrian government announce joint plans to drive long-term competitiveness of European production for key antibiotics in EuropePlanned combined investment of more than EUR 150 million would include major innovative technology development an…